Latest Strategic Collaboration News

Lefroy Exploration has received a second $0.75 million cash advance from BML Ventures, reinforcing its funding position ahead of key production milestones at the Lucky Strike Gold Project.

Elixir Energy has partnered with QGC to share 3D seismic data over a key Queensland gas permit, aiming to reduce risks ahead of the Daydream-3 appraisal well. This collaboration highlights the strategic importance of the Taroom Trough in Australia’s gas landscape.

Sovereign Metals has entered a strategic collaboration with the International Finance Corporation to advance sustainable development and financing of its Kasiya Rutile-Graphite Project in Malawi.

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.

Nanoveu’s subsidiary EMASS has teamed up with Semtech to integrate ultra-low-power AI with long-range LoRa connectivity, promising smarter, battery-efficient IoT devices for industrial and smart city applications.

West Coast Silver and Artemis Resources have signed a non-binding MOU to assess processing Elizabeth Hill silver ore at Artemis’s Radio Hill plant, aiming to fast-track development while managing capital costs.

Hazer Group has extended its collaboration with South Korean steel giant POSCO to further integrate its clean hydrogen and low-emissions graphite technology into low-carbon steel production.

Titomic Limited has successfully completed a hot fire test on a solid rocket motor thrust chamber made with its Titomic Kinetic Fusion cold spray technology, marking a significant milestone in aerospace additive manufacturing.

Delorean Corporation marks a pivotal shift to build-own-operate bioenergy projects with the completion of its $53 million Yarra Valley Water facility and strong progress on its SA1 Salisbury project, backed by $51.5 million in financing and robust market demand.

Imugene Limited and JW Therapeutics have launched a strategic collaboration to combine oncolytic virus and CAR-T cell therapies, aiming to tackle refractory solid tumors through a pioneering 'mark and kill' approach.

Race Oncology has received a $2.8 million Australian R&D tax refund for FY2025, with further overseas R&D rebates expected, bolstering its clinical development of innovative cancer therapies.

Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.